Cargando…
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
BACKGROUND: The lower burden of COVID-19 in tropical settings may be due to preexisting cross-immunity, which might vary according to geographical locations and potential exposure to other pathogens. We sought to assess the overall prevalence of SARS-CoV-2 antibodies and determine SARS-CoV-2 seropos...
Autores principales: | Aissatou, Abba, Fokam, Joseph, Semengue, Ezechiel Ngoufack Jagni, Takou, Désiré, Ka’e, Aude Christelle, Ambe, Collins Chenwi, Nka, Alex Durand, Djupsa, Sandrine Claire, Beloumou, Grâce, Ciaffi, Laura, Tchouaket, Michel Carlos Tommo, Nayang, Audrey Rachel Mundo, Pabo, Willy Leroi Togna, Essomba, René Ghislain, Halle, Edie G. E., Okomo, Marie-Claire, Bissek, Anne-Cecile ZK., Leke, Rose, Boum, Yap, Mballa, Georges Alain Etoundi, Montesano, Carla, Perno, Carlo-Federico, Colizzi, Vittorio, Ndjolo, Alexis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116492/ https://www.ncbi.nlm.nih.gov/pubmed/37090738 http://dx.doi.org/10.3389/fimmu.2023.1155855 |
Ejemplares similares
-
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
por: Fokam, Joseph, et al.
Publicado: (2022) -
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023) -
Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2022) -
Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon
por: Abba, Aissatou, et al.
Publicado: (2021) -
Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era
por: PABO, WILLY LE ROI TOGNA, et al.
Publicado: (2023)